Cargando…
Assessment and Management of Cardiotoxicity in Hematologic Malignancies
With the increasing overall survival of cancer patients due to recent discoveries in oncology, the incidence of side effects is also rising, and along with secondary malignancies, cardiotoxicity is one of the most concerning side effects, affecting the quality of life of cancer survivors. There are...
Autores principales: | Bojan, Anca, Torok-Vistai, Tunde, Parvu, Andrada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875649/ https://www.ncbi.nlm.nih.gov/pubmed/33613788 http://dx.doi.org/10.1155/2021/6616265 |
Ejemplares similares
-
Macrophage activation syndrome: A diagnostic challenge (Review)
por: Bojan, Anca, et al.
Publicado: (2021) -
Primary non-Hodgkin lymphoma of the orbit presenting with massive bilateral periorbital tumors
por: TŐRŐK-VISTAI, TÜNDE, et al.
Publicado: (2013) -
Pharmaceutical Prevention and Management of Cardiotoxicity in Hematological Malignancies
por: Perpinia, Anastasia Stella, et al.
Publicado: (2022) -
Ferritin level changes and erythroid improvement in a group of adult polytransfused patients treated with Deferasirox
por: PARVU, ANDRADA VIORICA, et al.
Publicado: (2018) -
Current therapeutic approaches in the management of hemophilia—a consensus view by the Romanian Society of Hematology
por: Hotea, Ionut, et al.
Publicado: (2021)